Clinical Trial Update: ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

View source ↗

Summary

This clinical trial update describes a study using circulating tumor DNA analysis to monitor the risk of disease progression after first-line immunotherapy in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fang Wu | Conditions: Advanced Lung Non-Small Cell Carcinoma | Status: RECRUITING